Transdermal Antibiotic Composition for Controlled Systemic Absorption
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Conventional antibiotic administration methods, such as oral ingestion and injections, pose adverse effects on the gastrointestinal system and have variable and unpredictable systemic absorption, leading to suboptimal therapeutic outcomes and risks of antibiotic-associated diarrhea and antibiotic-resistant organisms.
Innovation Solution
A transdermal antibiotic composition comprising antibiotics, polyphenols, and transdermal agents, which synergistically enhance dermal penetration and absorption, bypassing the gastrointestinal tract and ensuring consistent therapeutic levels in the bloodstream.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Ease of operation
If oral antibiotics are administered, then the treatment can be given conveniently, but the gastrointestinal system suffers adverse effects and the absorption is variable and unpredictable
Solution Approach 1:
The patent introduces the skin and transdermal delivery system as an intermediary route between the antibiotic and the gastrointestinal system. The topical composition applied to the skin serves as a mediator that enables systemic antibiotic delivery while bypassing the harmful gastrointestinal pathway entirely, thus resolving the contradiction between convenience and gastrointestinal safety
Solution Approach 2:
The invention extracts the antibiotic delivery function from the gastrointestinal tract and relocates it to the transdermal route. By removing the gastrointestinal administration pathway and replacing it with skin absorption, the harmful effects on the gut microbiota and gastrointestinal system are eliminated while maintaining the essential function of systemic antibiotic delivery
2Reliability
If injections are used for antibiotic administration, then the bioavailability is improved, but the risks associated with systemic delivery methods increase
Solution Approach 1:
The patent applies local quality by using the skin as a localized entry point for systemic delivery. The topical composition is applied locally to the skin surface, and the antibiotic is gradually absorbed through the skin layers into the bloodstream, providing reliable bioavailability while avoiding the high risks associated with direct injection methods
Solution Approach 2:
The transdermal delivery system provides periodic, controlled release of the antibiotic through the skin over time. This sustained release mechanism ensures consistent bioavailability without the need for repeated injections, thereby maintaining reliability while reducing the cumulative risks of invasive systemic delivery methods
3Quantity of substance
If oral antibiotics are administered, then the treatment can reach the bloodstream, but the absorption is variable leading to under-dosing or overdosing
Solution Approach 1:
The transdermal delivery system provides continuous, controlled release of the antibiotic through the skin, ensuring steady and predictable plasma concentrations. This continuous action eliminates the peaks and troughs associated with oral dosing, achieving precise drug concentration control while maintaining adequate systemic absorption levels
4Object-affected harmful factors
If transdermal delivery is used, then the gastrointestinal system is bypassed, but the dermal penetration and absorption of antibiotics is limited by the stratum corneum barrier
Solution Approach 1:
The patent employs parameter changes by formulating the topical composition with specific excipients and penetration enhancers that modify the physical and chemical properties of the stratum corneum. These formulation parameters are optimized to increase the permeability of the skin barrier while maintaining the safety advantage of bypassing the gastrointestinal system
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
Minimizes gastrointestinal side effects, optimizes bioavailability, and enhances treatment efficacy by providing a controlled and sustained release of antibiotics, ensuring effective systemic delivery and improved patient safety.
Implementation Method 1
a transdermal antibiotic topical solution formulated with specific antibiotics, polyphenols, and transdermal agents. This formulation enhances dermal penetration and absorption of antibiotics
Implementation Method 2
The suspension agent incorporates specific polyphenolic compounds which synergistically enhances the therapeutic efficacy of the formulation
Implementation Method 3
transdermal absorption provides a more controlled and sustained release of antibiotics, maintaining consistent therapeutic levels in the bloodstream
Data Source
AI summary
A transdermal antibiotic composition and method of administration is provided. The antibiotic topical includes a lotion containing an antibiotic, a suspension agent, and a transdermal agent for dermal penetration and absorption. This composition allows for the administration of antibiotics through the skin, bypassing the gastrointestinal system, and avoiding adverse reactions associated with oral ingestion or injections. The suspension agent includes polyphenols, wherein the transdermal agent is able to provide for dermal penetration and the absorption of antibiotics in the bloodstream.